期刊文献+

高血压病患者转铁蛋白与β_2-微球蛋白和微量白蛋白的关系 被引量:3

Relationship between Transferrin and β_2-microglobulin and Microalbminuria in Patients with Hypertension
下载PDF
导出
摘要 目的:探讨原发性高血压病患者尿液中β_2-微球蛋白(β_2-MG)与尿微量白蛋白(mALB)和尿转铁蛋白(UTRF)的关系。方法:采用免疫比浊法检测尿β_2-MG、mALB和UTRF。结果:mALB和β_2-MG之间有显著的正相关关系(F=0.5(?),p<001),mALB和UTRF之间有显著的正相关关系(F=0.791,p<0.001),UTRF和β_2-MG之间有显著的正相关关系(F=0.54,p<0.001);单因素Linear Regression分析发现UTRF是mALB和β_2-MG的相关因子(p<0.001)。结论:UTRF升高的高血压病患者,mALB和β_2-MG均增加,UTRF、mALB和β_2-MG的测定可作为高血压患者早期肾损伤的一个理想的反应肾小球滤过功能的敏感指标。 Objective: To discuss relationship between transfemn (UTRF) β2-microglobulin (β2-MG) and microalbminuria (mALB) in patients with hypertension. Method: Detectd turbidity β2-MG,mALB and UTRF in urine by immunoturbidimetrical method. Results: Significantly positive correlations were observed between UTRF and β2-MG ( F=0.507, p〈0.001), mALB and UTRF ( F=0.791, p〈0.001 ), UTRF and β2-MGbetween (F=0.554, p〈0.001 ), respectively. Single factor Linear Regression analysis showed that UTRF was a related factor ofmALB and β2- MG (p〈0.001). Conclusion: MALB and β2-MG were increased with the enhance of UTRF in patients with hypertension,, UTRF, mALB and β2-MG determination could be used as sensitive and ideal indicators for estimation of glomerular filtration rate during the early kidney damage in patients with hypertension.
出处 《现代生物医学进展》 CAS 2008年第7期1299-1301,共3页 Progress in Modern Biomedicine
关键词 高血压 尿微量白蛋白 尿Β2-微球蛋白 尿转铁蛋白 Hypertension Microalbminuria β2-microglobulin Transferrin
  • 相关文献

参考文献3

二级参考文献18

  • 1Hiratsuka N, Shiba K, Nishide K, et al. Analysis of urinary albumin, transferring, N-acetylase-D-glucosidase and beta2microglobulin in patients with impaired glucose tolerance[J].Clin Lab Aual 1998,12(6). 351-353.
  • 2Parring HH, Jensen HE, Mongensen CE, et al. Increased urinary albumin excretion in begin essential hypertension[J].Lancet 1974,1: 231.
  • 3叶任高 陆再英.内科学[M](第五版)[M].北京人民卫生出版社,2001..
  • 4林青,福建医科大学学报,1998年,32卷,50页
  • 5魏有仁,生物化学与生物物理进展,1995年,22卷,169页
  • 6Wu J T,J Clin Lab Anal,1993年,7卷,252页
  • 7于宏,实用高血压学,1993年,878页
  • 8National Kidney Foundation.Kidney Disease Outcome Quality Initiative.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Am J Kidney Dis,2002,39(2 Suppl 2):S1~246.
  • 9Keevil GB,Kilpatrick ES,Nichols SP,et al.Biological variation of Cystatin C:implication for the assessment of glomerular filtration rate.Clin Chem.1998,44(7):1 535~1 539.
  • 10Filer G,Prien F,Vollmer I,et al.Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate.Pediatr Nephrol,1999,13(6):501~505.

共引文献262

同被引文献51

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部